The prevalence of metabolic syndrome in patients with hidradenitis suppurativa

被引:143
作者
Gold, Daniel A. [1 ]
Reeder, Virginia J. [1 ]
Mahan, Meredith G. [2 ]
Hamzavi, Iltefat H. [1 ]
机构
[1] Henry Ford Med Ctr, Dept Dermatol, Detroit, MI 48202 USA
[2] Henry Ford Med Ctr, Dept Publ Hlth Sci, Detroit, MI 48202 USA
关键词
acne inversa; dyslipidemia; glucose intolerance; hidradenitis suppurativa; hypertension; metabolic syndrome; obesity; Velpeau disease; Verneuil disease; RHEUMATOID-ARTHRITIS; NATIONAL-HEALTH; PSORIASIS; DISEASE; MORTALITY; AGE;
D O I
10.1016/j.jaad.2013.11.014
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Metabolic syndrome is a multifaceted disorder strongly associated with increased risk for development of cardiovascular disease. Chronic inflammatory diseases have been associated with metabolic syndrome. Hidradenitis suppurativa is a chronic inflammatory skin disease with significant physical and emotional sequelae. Objective: We sought to investigate a possible association between hidradenitis suppurativa and metabolic syndrome. Methods: A retrospective chart review of all dermatology clinic encounters over an 18-month period identified 366 patients with an appropriate diagnosis of hidradenitis suppurativa. A control population was created from patients seen in the same clinic during the same time period for the diagnoses of either keloids or verruca vulgaris using the matching criteria of age 65 years, race, and gender. All participants were examined for characteristics of the metabolic syndrome as defined by the National Cholesterol Education Program Adult Treatment Program III guidelines. Results: The prevalence of metabolic syndrome in patients with hidradenitis suppurativa was 50.6%, which was significantly higher than the control group at 30.2% (P<.001). Limitations: This was a retrospective review. Some participants could not be analyzed for metabolic syndrome presence as a result of missing data points. Conclusion: Our results indicate that patients with hidradenitis suppurativa may be at high risk for metabolic syndrome.
引用
收藏
页码:699 / 703
页数:5
相关论文
共 31 条
[1]   Comorbidities associated with psoriasis: An experience from the Middle East [J].
Al-Mutairi, Nawaf ;
Al-Farag, Shahat ;
Al-Mutairi, Ahmed ;
Al-Shiltawy, Mazen .
JOURNAL OF DERMATOLOGY, 2010, 37 (02) :146-155
[2]   Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany [J].
Augustin, Matthias ;
Reich, Kristian ;
Glaeske, Gerd ;
Schaefer, Ines ;
Radtke, Marc .
ACTA DERMATO-VENEREOLOGICA, 2010, 90 (02) :147-151
[3]   Psoriasis and metabolic disease: epidemiology and pathophysiology [J].
Azfar, Rahat S. ;
Gelfand, Joel M. .
CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (04) :416-422
[4]   Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis [J].
Chung, Cecilia P. ;
Oeser, Annette ;
Solus, Joseph F. ;
Avalos, Ingrid ;
Gebretsadik, Tebeb ;
Shintani, Ayurni ;
Raggi, Paolo ;
Sokka, Tuulikki ;
Pincus, Theodore ;
Stein, C. Michael .
ATHEROSCLEROSIS, 2008, 196 (02) :756-763
[5]   Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States [J].
Cosmatos, Irene ;
Matcho, Amy ;
Weinstein, Rachel ;
Montgomery, Michael O. ;
Stang, Paul .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (03) :412-419
[6]  
da Cunha VR, 2011, REV BRAS REUMATOL, V51, P260
[7]   Psoriasis and Systemic Inflammatory Diseases: Potential Mechanistic Links between Skin Disease and Co-Morbid Conditions [J].
Davidovici, Batya B. ;
Sattar, Naveed ;
Joerg, Prinz C. ;
Puig, Luis ;
Emery, Paul ;
Barker, Jonathan N. ;
van de Kerkhof, Peter ;
Stahle, Mona ;
Nestle, Frank O. ;
Girolomoni, Giampiero ;
Krueger, James G. .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2010, 130 (07) :1785-1796
[8]  
Dessein PH, 2013, CLIN EXP RHEUMATOL, V31, P53
[9]  
Ervin R Bethene, 2009, Natl Health Stat Report, P1
[10]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359